{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:34:20Z","timestamp":1792650860172,"version":"4.5.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,20]]},"DOI":"10.4103\/0366-6999.204101","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T10:09:59Z","timestamp":1491818999000},"page":"906-913","source":"Crossref","is-referenced-by-count":21,"title":["Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy"],"prefix":"10.1097","volume":"130","author":[{"given":"Jia-Nan","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-Sha","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Sheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3760\/cma.j.issn.0366-6999.20132318","article-title":"Baseline proteinuria, urinary osmotic pressure, and renal function as positive predictors of corticosteroids plus cyclophosphamide treatment efficacy in IgA nephropathy","volume":"127","author":"Fang","year":"2014","journal-title":"Chin Med J"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","article-title":"Long-term renal survival and related risk factors in patients with IgA nephropathy: Results from a cohort of 1155 cases in a Chinese adult population","volume":"27","author":"Le","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cphy.c120028","article-title":"Immune and inflammatory role in renal disease","volume":"3","author":"Imig","year":"2013","journal-title":"Compr Physiol"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrneph.2010.16","article-title":"The role of Toll-like receptors in renal diseases","volume":"6","author":"Gluba","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int Immunol"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"F304","DOI":"10.1152\/ajprenal.00237.2006","article-title":"Toll-like receptor (TLR4) shedding and depletion: Acute proximal tubular cell responses to hypoxic and toxic injury","volume":"292","author":"Zager","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MNH.0b013e32803fb767","article-title":"Toll-like receptors: Emerging concepts in kidney disease","volume":"16","author":"Anders","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3349\/ymj.2011.52.4.610","article-title":"Toll-like receptor 4 signaling is involved in IgA-stimulated mesangial cell activation","volume":"52","author":"Lim","year":"2011","journal-title":"Yonsei Med J"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1681\/ASN.2009070722","article-title":"TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury","volume":"21","author":"Pulskens","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"c97","DOI":"10.1159\/000324765","article-title":"Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-\u00df1 in patients with chronic kidney disease","volume":"119","author":"Lepenies","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ki.2010.381","article-title":"Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury","volume":"79","author":"Chen","year":"2011","journal-title":"Kidney Int"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.172.4.2629","article-title":"Role of Toll-like receptor 4 in endotoxin-induced acute renal failure","volume":"172","author":"Cunningham","year":"2004","journal-title":"J Immunol"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1523-1755.2005.00354.x","article-title":"Relevance of Toll-like receptor-4 polymorphisms in renal transplantation","volume":"67","author":"Ducloux","year":"2005","journal-title":"Kidney Int"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone clinical trial in macrovascular events): A randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2249.2009.04045.x","article-title":"Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy","volume":"159","author":"Coppo","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R16-5-20210129","first-page":"626","article-title":"Innate immunity and IgA nephropathy","volume":"23","author":"Coppo","year":"2010","journal-title":"J Nephrol"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/08923973.2015.1080265","article-title":"Anti-inflammatory effects of triptolide on IgA nephropathy in rats","volume":"37","author":"He","year":"2015","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MNH.0b013e32834de526","article-title":"PPAR\u03b3 as a therapeutic target in diabetic nephropathy and other renal diseases","volume":"21","author":"Yang","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00467-010-1703-y","article-title":"Additive effect of PPAR-\u03b3 agonist and ARB in treatment of experimental IgA nephropathy","volume":"26","author":"Lai","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/ndt\/gfn746","article-title":"Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy","volume":"24","author":"Xiao","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clim.2009.04.004","article-title":"Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy","volume":"132","author":"Xiao","year":"2009","journal-title":"Clin Immunol"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10616-015-9893-6","article-title":"PPAR\u03b3 ameliorated LPS induced inflammation of HEK cell line expressing both human Toll-like receptor 4 (TLR4) and MD2","volume":"68","author":"Darehgazani","year":"2016","journal-title":"Cytotechnology"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10753-015-0116-2","article-title":"Intensive atorvastatin therapy attenuates the inflammatory responses in monocytes of patients with unstable angina undergoing percutaneous coronary intervention via peroxisome proliferator-activated receptor \u03b3 activation","volume":"38","author":"Yang","year":"2015","journal-title":"Inflammation"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1465-9921-15-28","article-title":"PPAR\u03b3 agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages","volume":"15","author":"Yin","year":"2014","journal-title":"Respir Res"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"F143","DOI":"10.1152\/ajprenal.00398.2012","article-title":"The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules","volume":"305","author":"Mudaliar","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ki.1992.268","article-title":"Glomerular hemodynamics and eicosanoid synthesis in a rat model of IgA nephropathy","volume":"42","author":"Gesualdo","year":"1992","journal-title":"Kidney Int"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1203\/00006450-199610000-00018","article-title":"Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy","volume":"40","author":"Trachtman","year":"1996","journal-title":"Pediatr Res"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s004670050573","article-title":"Influence of alpha-tocopherol over the time course of experimental IgA nephropathy","volume":"13","author":"Kuemmerle","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.150.5.1161","article-title":"Experimental IgA nephropathy","volume":"150","author":"Rifai","year":"1979","journal-title":"J Exp Med"},{"key":"R31-5-20210129","first-page":"463","article-title":"IgA nephropathy: Lessons from an animal model, the ddY mouse","volume":"21","author":"Tomino","year":"2008","journal-title":"J Nephrol"},{"key":"R32-5-20210129","first-page":"609","article-title":"Repair effects of umbilical cord mesenchymal stem cells on podocyte damage of IgA nephropathy","volume":"29","author":"Zhang","year":"2015","journal-title":"J Biol Regul Homeost Agents"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33549\/physiolres.932380","article-title":"Temporal and spatial expression of podocyte-associated molecules are accompanied by proteinuria in IgA nephropathy rat model","volume":"62","author":"Lu","year":"2013","journal-title":"Physiol Res"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1242\/jcs.167858","article-title":"GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway","volume":"128","author":"Menon","year":"2015","journal-title":"J Cell Sci"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/anie.201004655","article-title":"Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling","volume":"50","author":"Piazza","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1084\/jem.157.2.572","article-title":"Experimental IgA nephropathy induced by oral immunization","volume":"157","author":"Emancipator","year":"1983","journal-title":"J Exp Med"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10157-004-0324-9","article-title":"Novel mechanisms of tubulointerstitial injury in IgA nephropathy: A new therapeutic paradigm in the prevention of progressive renal failure","volume":"8","author":"Chan","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1711750311","article-title":"In vitro effects of interleukins on human mesangial cells: Implications for glomerulonephritis","volume":"175","author":"Chen","year":"1995","journal-title":"J Pathol"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ki.1993.317","article-title":"In situ expression of cytokines in IgA nephritis","volume":"44","author":"Yoshioka","year":"1993","journal-title":"Kidney Int"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 activation mediates kidney ischemia\/reperfusion injury","volume":"117","author":"Wu","year":"2007","journal-title":"J Clin Invest"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.transproceed.2008.06.073","article-title":"Toll-like receptor expression in patients with renal allograft dysfunction","volume":"40","author":"Kwon","year":"2008","journal-title":"Transplant Proc"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0253-7613.150319","article-title":"Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy","volume":"47","author":"Chen","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cellimm.2006.08.002","article-title":"BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT","volume":"241","author":"McCarthy","year":"2006","journal-title":"Cell Immunol"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1681\/ASN.2007040395","article-title":"TLR4 links podocytes with the innate immune system to mediate glomerular injury","volume":"19","author":"Banas","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2010.01.073","article-title":"Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells","volume":"1322","author":"Wu","year":"2010","journal-title":"Brain Res"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/en.2008-1757","article-title":"Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db\/db mice","volume":"150","author":"Dasu","year":"2009","journal-title":"Endocrinology"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cyto.2011.05.020","article-title":"PPAR\u03b3 agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4\/TRIF\/IRF3\/IP-10 signaling pathway","volume":"55","author":"Ji","year":"2011","journal-title":"Cytokine"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1074\/jbc.M110.149823","article-title":"Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter","volume":"286","author":"Zhao","year":"2011","journal-title":"J Biol Chem"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.204101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:39:19Z","timestamp":1750196359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201704200-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.204101","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}